{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:39:12Z","timestamp":1790919552055,"version":"4.1.0"},"reference-count":53,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2004,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>During the recent bioterrorism-related outbreaks, inhalational anthrax had a 45% mortality in spite of appropriate antimicrobial therapy, underscoring the need for better adjuvant therapies. The variable latency between exposure and development of disease suggests an important role for the host's innate immune response. Alveolar macrophages are likely the first immune cells exposed to inhalational anthrax, and the interferon (IFN) response of these cells comprises an important arm of the host innate immune response to intracellular infection with<jats:italic>Bacillus anthracis<\/jats:italic>. Furthermore, IFNs have been used as immunoadjuvants for treatment of another intracellular pathogen,<jats:italic>Mycobacterium tuberculosis<\/jats:italic>. We established a model of<jats:italic>B. anthracis<\/jats:italic>infection with the Sterne strain (34F<jats:sub>2<\/jats:sub>) which contains lethal toxin (LeTx). 34F<jats:sub>2<\/jats:sub>was lethal to murine and human macrophages. Treatment with IFNs significantly improved cell viability and reduced the number of germinated intracellular spores. Infection with 34F<jats:sub>2<\/jats:sub>failed to induce the latent transcription factors signal transducer and activators of transcription 1 (STAT1) and ISGF-3, which are central to the IFN response. Furthermore, 34F<jats:sub>2<\/jats:sub>reduced STAT1 activation in response to exogenous alpha\/beta IFN, suggesting direct inhibition of IFN signaling. Even though 34F<jats:sub>2<\/jats:sub>has LeTx, there was no mitogen-activated protein kinase kinase 3 cleavage and p38 was normally induced, suggesting that these early effects of<jats:italic>B. anthracis<\/jats:italic>infection in macrophages are independent of LeTx. These data suggest an important role for both IFNs in the control of<jats:italic>B. anthracis<\/jats:italic>and the potential benefit of using exogenous IFN as an immunoadjuvant therapy.<\/jats:p>","DOI":"10.1128\/iai.72.3.1291-1297.2004","type":"journal-article","created":{"date-parts":[[2004,2,21]],"date-time":"2004-02-21T04:42:58Z","timestamp":1077338578000},"page":"1291-1297","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":40,"title":["Exogenous Gamma and Alpha\/Beta Interferon Rescues Human Macrophages from Cell Death Induced by<i>Bacillus anthracis<\/i>"],"prefix":"10.1128","volume":"72","author":[{"given":"Jeffrey A.","family":"Gold","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus B.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Sackler Institute of Biomedical Studies, New York University School of Medicine, New York, New York 10016"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nolan","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Weiden","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0882-4010(89)90022-3"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.1.213"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.4.1111"},{"key":"e_1_3_2_5_2","first-page":"2058","volume":"71","year":"2002","unstructured":"Condos, R., B. Raju, A. Canova, M. Zhao, M. Weiden, W. N. Rom, and R. Pine. 2002. Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients. Infect. Immun.71:2058-2064.","journal-title":"Infect. Immun."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)12273-X"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8456300"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.12.7050"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(91)90014-3"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.7.3279"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1462-5822.2000.00067.x"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5364.734"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.2.1175-1177.2001"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.21.8555"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.4.9803065"},{"key":"e_1_3_2_16_2","first-page":"99","volume":"11","year":"2000","unstructured":"Giosue, S., M. Casarini, F. Ameglio, P. Zangrilli, M. Palla, A. M. Altieri, and A. Bisetti. 2000. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis. Eur. Cytokine Netw.11:99-104.","journal-title":"Eur. Cytokine Netw."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.20.5601"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230237"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2001.02695.x"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011614"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8456301"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.17.2236"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.10.5870-5872.2002"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0810.020353"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.19-5-378"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00336-9"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(00)00027-7"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/107999002753452692"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.7.1845"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81288-X"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7973702"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.55.1.647"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612263352602"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/107999003765027384"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M105070200"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.1522"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.202476699"},{"key":"e_1_3_2_38_2","first-page":"214","volume":"3","year":"1999","unstructured":"Palmero, D., K. Eiguchi, P. Rendo, L. Castro Zorrilla, E. Abbate, and L. J. Gonzalez Montaner. 1999. Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up. Int. J. Tuberc. Lung Dis.3:214-218.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(99)01502-1"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.4.1419"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(02)03228-3"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)00227-9"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.5.2487-2497.2003"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.62.1.114-119.1988"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.1.366"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208633200"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1998.00953.x"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.67.1.227"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.1.466"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.4049\/jimmunol.163.7.3898","volume":"163","year":"1999","unstructured":"Ting, L. M., A. C. Kim, A. Cattamanchi, and J. D. Ernst. 1999. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J. Immunol.163:3898-3906.","journal-title":"J. Immunol."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.42.30127"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(01)00476-6"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.4.2028"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90311-9"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.3.1291-1297.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.3.1291-1297.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:26:26Z","timestamp":1682641586000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.72.3.1291-1297.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1128\/IAI.72.3.1291-1297.2004"],"URL":"https:\/\/doi.org\/10.1128\/iai.72.3.1291-1297.2004","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"2003-08-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-11-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}